ERBB2 and lung carcinoma: Ganti Ganti AK AK Rothe Rothe M M Mangat Mangat PK PK Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study Jco Precis Oncol Jco Precis Oncol 2023 2023 7 7 e2300041 e2300041 10.1200/PO.23.00041 10.1200/PO.23.00041 supplied-pmid 37315265?